Abstract
IGF-I and -II levels are altered in patients with atherogenic lipid profiles and may contribute to the development of macrovascular disease in NIDDM. We examined cardiovascular risk factors, IGF-I, IGF-II and IGFBP-1 in 74 NIDDM patients analysed as a whole group and according to treatment type. IGF-I was not significantly associated with cardiovascular risk factors but IGF-II levels correlated positively with total and LDL cholesterol most markedly in the diet treated group (0.72, p
Original language | English |
---|---|
Pages (from-to) | 860-863 |
Number of pages | 4 |
Journal | Journal of Clinical Endocrinology & Metabolism |
Volume | 81 |
Issue number | 2 |
Publication status | Published - 1996 |